These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 17597218)
1. The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Gwilt CR; Donnelly LE; Rogers DF Pharmacol Ther; 2007 Aug; 115(2):208-22. PubMed ID: 17597218 [TBL] [Abstract][Full Text] [Related]
2. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD. Kistemaker LE; Oenema TA; Meurs H; Gosens R Life Sci; 2012 Nov; 91(21-22):1126-33. PubMed ID: 22406302 [TBL] [Abstract][Full Text] [Related]
4. The non-neuronal cholinergic system as novel drug target in the airways. Pieper MP Life Sci; 2012 Nov; 91(21-22):1113-8. PubMed ID: 22982180 [TBL] [Abstract][Full Text] [Related]
5. Control by cholinergic mechanisms. Racké K; Juergens UR; Matthiesen S Eur J Pharmacol; 2006 Mar; 533(1-3):57-68. PubMed ID: 16458288 [TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target. Meurs H; Dekkers BG; Maarsingh H; Halayko AJ; Zaagsma J; Gosens R Pulm Pharmacol Ther; 2013 Feb; 26(1):145-55. PubMed ID: 22842340 [TBL] [Abstract][Full Text] [Related]
8. Acetylcholine: a novel regulator of airway smooth muscle remodelling? Gosens R; Zaagsma J; Grootte Bromhaar M; Nelemans A; Meurs H Eur J Pharmacol; 2004 Oct; 500(1-3):193-201. PubMed ID: 15464033 [TBL] [Abstract][Full Text] [Related]
9. Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling. Kistemaker LE; Gosens R Trends Pharmacol Sci; 2015 Mar; 36(3):164-71. PubMed ID: 25511176 [TBL] [Abstract][Full Text] [Related]
10. The Non-neuronal cholinergic system: an emerging drug target in the airways. Wessler IK; Kirkpatrick CJ Pulm Pharmacol Ther; 2001; 14(6):423-34. PubMed ID: 11782122 [TBL] [Abstract][Full Text] [Related]
11. Differences of inflammatory mechanisms in asthma and COPD. Ichinose M Allergol Int; 2009 Sep; 58(3):307-13. PubMed ID: 19628975 [TBL] [Abstract][Full Text] [Related]
12. Eosinophilic airway disorders. Scott KA; Wardlaw AJ Semin Respir Crit Care Med; 2006 Apr; 27(2):128-33. PubMed ID: 16612763 [TBL] [Abstract][Full Text] [Related]
13. Adenosine in the airways: implications and applications. Spicuzza L; Di Maria G; Polosa R Eur J Pharmacol; 2006 Mar; 533(1-3):77-88. PubMed ID: 16458886 [TBL] [Abstract][Full Text] [Related]
15. A new perspective on muscarinic receptor antagonism in obstructive airways diseases. Meurs H; Oenema TA; Kistemaker LE; Gosens R Curr Opin Pharmacol; 2013 Jun; 13(3):316-23. PubMed ID: 23643733 [TBL] [Abstract][Full Text] [Related]
16. Vagus nerve participates in regulation of the airways: inflammatory response and hyperreactivity induced by occupational asthmogens. Lutz W; Sułkowski WJ Int J Occup Med Environ Health; 2004; 17(4):417-31. PubMed ID: 15852756 [TBL] [Abstract][Full Text] [Related]
17. The airway cholinergic system: physiology and pharmacology. Racké K; Matthiesen S Pulm Pharmacol Ther; 2004; 17(4):181-98. PubMed ID: 15219263 [TBL] [Abstract][Full Text] [Related]
18. Cells, mediators and Toll-like receptors in COPD. Sarir H; Henricks PA; van Houwelingen AH; Nijkamp FP; Folkerts G Eur J Pharmacol; 2008 May; 585(2-3):346-53. PubMed ID: 18410916 [TBL] [Abstract][Full Text] [Related]
19. Airway smooth muscle and immunomodulation in acute exacerbations of airway disease. Koziol-White CJ; Panettieri RA Immunol Rev; 2011 Jul; 242(1):178-85. PubMed ID: 21682745 [TBL] [Abstract][Full Text] [Related]